Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous useInitial U.S. Approval: 1985
Medication labelWhy this: Advisory · dailymed-prescription
FENSOLVI is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).
- generic_name
- leuprolide acetate
- brand_name
- atrigel
- product_names
- Leuprolide Acetate, atrigel
- ndc
- 62935-153, 62935-153-50, 62935-154, 62935-154-50, 62935-155, 62935-155-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en